C07K 16/42
Against immunoglobulins
Official title: against immunoglobulins
C07K16/42 (Against immunoglobulins) appears on 1,088 US grants and 1,592 published applications in this corpus.
Search patents in C07K- Granted patents
- 1,088
- Published applications
- 1,592
- Assignees
- 706
- Inventors
- 2,981
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 2 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 4 | 0 |
| 1988 | 3 | 0 |
| 1989 | 10 | 0 |
| 1990 | 4 | 0 |
| 1991 | 5 | 0 |
| 1992 | 13 | 0 |
| 1993 | 17 | 0 |
| 1994 | 17 | 0 |
| 1995 | 16 | 0 |
| 1996 | 21 | 0 |
| 1997 | 31 | 0 |
| 1998 | 34 | 0 |
| 1999 | 40 | 0 |
| 2000 | 26 | 0 |
| 2001 | 34 | 8 |
| 2002 | 23 | 35 |
| 2003 | 20 | 49 |
| 2004 | 21 | 51 |
| 2005 | 20 | 53 |
| 2006 | 15 | 46 |
| 2007 | 21 | 49 |
| 2008 | 26 | 45 |
| 2009 | 20 | 57 |
| 2010 | 31 | 61 |
| 2011 | 22 | 48 |
| 2012 | 33 | 57 |
| 2013 | 37 | 44 |
| 2014 | 34 | 74 |
| 2015 | 38 | 65 |
| 2016 | 35 | 79 |
| 2017 | 51 | 65 |
| 2018 | 31 | 64 |
| 2019 | 35 | 59 |
| 2020 | 33 | 85 |
| 2021 | 39 | 93 |
| 2022 | 42 | 83 |
| 2023 | 43 | 96 |
| 2024 | 48 | 76 |
| 2025 | 51 | 99 |
| 2026 | 40 | 51 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Luciferase linked immunosorbent assay6 Oct 2026US 12,753,245 B2Institut Pasteur
- Immunoglobulin variable domains1 Sep 2026US 12,723,072 B2Ablynx N. V.
- Antibodies binding to GPRC5D25 Aug 2026US 12,715,923 B2Hoffmann-La Roche Inc.
- Anti-idiotype antibody molecules and uses thereof25 Aug 2026US 12,715,934 B2Otsuka Pharmaceutical Co., Ltd.
- Methods and compositions for inducible extracellular membrane capture of monoclonal immunoglobulins secreted by hybridomas25 Aug 2026US 12,715,935 B2Lankenau Institute for Medical Research
- Thin Wall Cannula8 Oct 2026US 2026/0306753 A1Becton, Dickinson and Company
- Methods and compositions for in situ identification of protein-nucleic acid interaction sites8 Oct 2026US 2026/0308279 A1The Regents of the University of California
- Treatment of food allergy using anti-ige antibodies8 Oct 2026US 2026/0308280 A1Novartis AG
- Process of affinity chromatography1 Oct 2026US 2026/0295463 A1Kashiv Biosciences, LLC
- Engineered artificial antigen presenting cells for tumor infiltrating lymphocyte expansion17 Sep 2026US 2026/0274920 A1Iovance Biotherapeutics, Inc.
Most cited
By later US patents
- Ransgenic non-human animals for producing heterologous antibodies1,941US 5,545,806 AGenPharm International, Inc. · 1996
- Transgenic non-human animals capable of producing heterologous antibodies of various isotypes1,748US 5,569,825 AGenPharm International, Inc. · 1996
- Transgenic non-human animals capable of producing heterologous antibodies1,680US 5,633,425 AGenPharm International, Inc. · 1997
- Transgenic non-human animals for producing heterologous antibodies1,604US 5,625,126 AGenPharm International, Inc. · 1997
- Polypeptide variants with altered effector function1,378US 6,737,056 B1Genentech, Inc. · 2004